Possible endocannabinoid control of colorectal cancer growth (Q44569526)

4 December 2017

Possible endocannabinoid control of colorectal cancer growth (English)

1 reference

4 December 2017

0 references

1 reference

1 reference

9

1 reference

4 December 2017

11

1 reference

4 December 2017

Luciano De Petrocellis

4

object named as

Luciano De Petrocellis

1 reference

4 December 2017

Alessia Ligresti

1

1 reference

4 December 2017

Tiziana Bisogno

2

1 reference

4 December 2017

Isabel Matias

3

1 reference

4 December 2017

Maria Grazia Cascio

5

1 reference

4 December 2017

Vittorio Cosenza

6

1 reference

4 December 2017

Giuseppe D'argenio

7

1 reference

4 December 2017

Giuseppe Scaglione

8

1 reference

4 December 2017

Italo Sorrentini

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

125

1 reference

4 December 2017

677-687

1 reference

4 December 2017

3

1 reference

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Targeting the endocannabinoid system in cancer therapy: a call for further research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Antineoplastic Activity of Cannabinoids2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Control of the cell survival/death decision by cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Cyclooxygenase-2: a novel target for cancer chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Lysophospholipid mediators of immunity and neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

The endogenous cannabinoid system controls extinction of aversive memories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Endocannabinoids Part I: molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

Anandamide and other N-acylethanolamines in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900881-3

10.1016/S0016-5085(03)00881-3

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference